Camlin Fine Sciences Limited Stock Price Today (NSE: CAMLINFINE)

Camlin Fine Sciences Limited

99.63+1.51 (+1.54%)
Market Closed

Fundamental Score

...

Camlin Fine Sciences Limited Share Price — Live NSE/BSE Price, Fundamentals & Analysis

Camlin Fine Sciences Limited share price today is 99.63, up +1.54% on NSE/BSE as of 17 September 2026. Camlin Fine Sciences Limited (CAMLINFINE) is a Small-cap company in the Specialty Chemicals sector with a market capitalisation of 1.91K (Cr). The 52-week high for CAMLINFINE share price is 235.00 and the 52-week low is 96.21. At a P/E ratio of 369.00x, CAMLINFINE is currently trading above its industry average P/E of 31.95x. The company has a Return on Equity (ROE) of 2.84% and a debt-to-equity ratio of 0.64.

Camlin Fine Sciences Limited Share Price Chart — NSE/BSE Historical Performance

No data
High
128.89
Low
99.00
Volume
17.0L
Change
-16.26%

Camlin Fine Sciences Limited share price chart: -16.26% return over the past month. 52-week high ₹235.00, 52-week low ₹96.21.

Camlin Fine Sciences Limited — Last 10 Trading Days

DateOpenHighLowCloseVolume
98.12102.8798.1299.6310.65L (Cr)
100.00100.9997.1098.123.80L (Cr)
101.86103.9097.7599.216.35L (Cr)
102.57102.65100.89101.683.89L (Cr)
104.00106.00103.11103.573.20L (Cr)
104.15105.30102.84103.803.99L (Cr)
102.70106.62101.62104.1511.19L (Cr)
103.90103.90101.10101.682.84L (Cr)
102.90105.37102.10103.136.89L (Cr)
103.60105.0099.00102.2818.60L (Cr)

Camlin Fine Sciences Limited — Last 12 Months Price History

MonthOpenHighLowCloseChange
102.75106.6297.1099.63-3.04%
125.25133.80101.15102.63-18.06%
134.30139.80118.75127.74-4.88%
123.00146.50113.50133.38+8.44%
126.94140.00115.91122.05-3.85%
100.00134.5097.89126.94+26.94%
141.05147.1796.2196.93-31.28%
138.90192.00136.22147.90+6.48%
148.58166.59135.00145.27-2.23%
163.91169.89141.00148.40-9.46%
195.00201.79148.99164.92-15.43%
196.00211.95179.00195.90-0.05%

Returns & Performance

Poor

Return on Equity (ROE)

2.84%

Profit generated per ₹1 of shareholder equity

Poor

Return on Capital (ROCE)

3.11%

Returns generated on total capital deployed

Good

Oper. Profit Margin (5Y Avg)

11.34%

Average operating profit margin over 5 years

Dividend Yield

0.00%

Annual dividend as % of current share price

Camlin Fine Sciences Limited Valuation Check

Poor

Price to Earnings (P/E)

369.00x

Share price ÷ earnings per share. Lower = cheaper

Poor

Industry Avg P/E

31.95x

Average P/E of all peers in this sector

Market-cap Classification
Small-cap
Higher growth potential with higher volatility.

Shareholding Pattern

Excellent

Promoter Holding

48.03%

% shares held by company founders/management

Poor

FII Holding

0.94%

% shares held by foreign institutional investors

Average

DII Holding

7.70%

% held by domestic mutual funds, LIC, banks

Poor

Promoter Pledged %

16.58%

% of promoter shares pledged as collateral — lower is safer

Growth Engine

Excellent

Profit Growth (Quarterly YoY)

218.31%

Net profit growth vs same quarter last year

Excellent

Revenue Growth (Quarterly YoY)

22.74%

Revenue growth vs same quarter last year

Poor

Revenue Growth (5-Year CAGR)

7.74%

Compounded annual revenue growth over 5 years

Poor

EPS Growth (5-Year CAGR)

-18.78%

Earnings per share growth over 5 years

Poor

Net Profit Growth (5-Year CAGR)

-11.53%

Compounded annual net profit growth over 5 years

Balance Sheet Health

Poor

Debt to Equity Ratio

0.64x

Total debt ÷ equity. Below 0.5 = financially healthy

Poor

Interest Coverage Ratio

0.54x

EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably

Free Cash Flow (5-Year Total)

-74.57 (Cr)

Cash left after capex over 5 years. Positive = self-funded growth

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Camlin Fine Sciences Limited Fundamental Analysis & Valuation Benchmarking

Educational evaluation of CAMLINFINE across key market metrics for learning purposes.

Positive Indicators

2 factors identified

Robust Profit Growth (218.31%)

Observation: Strong year-over-year profit expansion demonstrates business momentum.

Analysis: Profit growth >20% indicates effective execution and market opportunity capture.

Strong Revenue Growth (22.74%)

Observation: Healthy sales growth indicates market demand and execution capability.

Analysis: Revenue growth >15% suggests strong market position and growth potential.

Risk Factors

9 factors identified

Below-Average Return on Equity (2.84%)

Observation: Returns on equity are below industry benchmarks.

Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.

Suboptimal ROCE (3.11%)

Observation: Returns on capital employed are below expectations.

Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.

Premium Valuation Risk (P/E: 369.00x)

Observation: High valuation multiples may limit upside potential.

Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.

Weak Earnings Growth (-18.78% CAGR)

Observation: Below-average 5-year EPS growth performance.

Analysis: Low EPS growth may not keep pace with inflation.

Stagnant Profit Growth (-11.53% CAGR)

Observation: Limited 5-year profit growth trajectory.

Analysis: Low profit growth may indicate scalability challenges or market maturity.

Weak Interest Coverage (0.54x)

Observation: Limited ability to service debt obligations from earnings.

Analysis: Low interest coverage raises concerns about financial stability.

Negative Free Cash Flow (₹-74.57 Cr over 5Y)

Observation: Cash outflows exceed inflows.

Analysis: Negative FCF requires analysis of capital expenditure cycle.

Limited Institutional Interest (FII+DII: 8.64%)

Observation: Low institutional participation may affect liquidity.

Analysis: Limited institutional interest may indicate size constraints or visibility issues.

No Dividend Distribution

Observation: Company does not currently pay dividends to shareholders.

Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.

Camlin Fine Sciences Limited vs Specialty Chemicals Peers

Peer Comparison - Specialty Chemicals

Compare Camlin Fine Sciences Limited with 10 other companies in the same sector

11 companies
Company Info
Fundamental
Valuation
Profitability
Financial Health
Growth
Dividend
Company
Company name
Score
Bull Run comprehensive fundamental score based on 20+ metrics
Price
Current trading price of the stock
Market Cap
Total value of all shares in the market
P/E
Price per share divided by earnings per share
ROE
Net income divided by shareholder equity
ROCE
Earnings before interest and tax divided by capital employed
Debt/Eq
Total debt divided by total equity
Profit 5Y
Average annual profit growth over 5 years
Sales 5Y
Average annual sales growth over 5 years
Dividend
Annual dividend per share divided by price per share
0/100
100
₹1913.89
369.0
Average
2.84%
Poor
3.11%
Poor
0.6
Good
-11.53%
Poor
7.74%
Good
0.00%
65.3/100
1574
₹160150.83
60.5
Average
23.79%
Excellent
29.92%
Excellent
0.0
Excellent
16.70%
Excellent
14.89%
Good
0.73%
42.9/100
4694
₹51636.20
84.3
Average
7.65%
Poor
10.87%
Average
0.3
Excellent
36.34%
Excellent
13.52%
Good
0.07%
62.7/100
8850
₹45397.93
57.4
Average
20.11%
Excellent
21.48%
Excellent
0.3
Excellent
20.84%
Excellent
22.95%
Excellent
0.20%
32.8/100
1665
₹22710.60
29.0
Average
9.81%
Poor
11.31%
Average
0.3
Excellent
-6.63%
Poor
12.59%
Good
0.44%
36.3/100
1629
₹21621.60
91.7
Average
9.38%
Poor
12.78%
Average
0.2
Excellent
0.00%
58.2/100
6282
₹18494.21
23.3
Average
11.47%
Average
14.24%
Average
0.0
Excellent
54.89%
Excellent
10.95%
Good
0.49%
38.7/100
498
₹18061.64
34.0
Average
7.25%
Poor
8.86%
Poor
0.8
Good
-4.35%
Poor
12.96%
Good
0.20%
52.2/100
3802
₹16458.86
25.6
Average
0.00%
Poor
14.04%
Average
0.0
Excellent
7.67%
Good
9.35%
Good
0.68%
62.09999999999999/100
5145
₹15774.57
36.0
Average
16.82%
Good
21.91%
Excellent
0.0
Excellent
28.23%
Excellent
15.86%
Excellent
0.21%
33.3/100
1225
₹13940.69
79.6
Average
5.50%
Poor
9.10%
Poor
0.5
Good
19.33%
Excellent
23.88%
Excellent
0.06%

Camlin Fine Sciences Limited PE Ratio History

Historical price-to-earnings ratio for CAMLINFINE — last 5 years

YearEPS (₹)Price (₹)P/E Ratio
FY 20233.33₹135.8040.8x
FY 20224.43₹160.1036.2x

P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.

Camlin Fine Sciences Limited Dividend History

Annual cash dividends paid by CAMLINFINE — dividend yield N/A

Financial YearDividends Paid (₹ Cr)
FY 202428.13 Cr
FY 202313.85 Cr
FY 20220.71 Cr
FY 20215.42 Cr

Cash dividends from annual cash flow statements. Past dividends do not guarantee future payments. Not investment advice.

Camlin Fine Sciences Limited Quarterly Performance

Latest quarterly metrics for CAMLINFINE — revenue growth and profit growth vs same quarter last year

Revenue Growth (YoY)

22.74%

Latest quarter vs same quarter previous year

Net Profit Growth (YoY)

218.31%

Latest quarter net profit vs same quarter previous year

5-Year Revenue CAGR

7.74%

Compounded annual revenue growth over 5 years

5-Year Profit CAGR

-11.53%

Compounded annual net profit growth over 5 years

Camlin Fine Sciences Limited Technical Indicators

SMA 50, SMA 200, RSI and volume signals for CAMLINFINE — calculated from daily price history

44RSI 14
Neutral — RSI 44

Momentum is balanced — neither overbought nor oversold.

SMA 50
119
▼ Price below SMA 50 — Short-term bearish
SMA 200
133
▼ Price below SMA 200 — Long-term downtrend
30-Day Avg Volume
1368K shares/day
Average daily traded volume over last 30 trading sessions

Technical indicators are for educational purposes only. Not investment advice.

Camlin Fine Sciences Limited Financial Statements

Annual income statement, balance sheet and cash flow for Camlin Fine Sciences Limited (CAMLINFINE) — sourced from NSE/BSE filings.

Financial Results & Statements

Latest quarterly, annual and period-wise financial data for Camlin Fine Sciences Limited

Loading latest quarterly results...

About CAMLINFINE (Camlin Fine Sciences Limited)

Camlin Fine Sciences Ltd is a dynamic force in the specialty chemicals sector, dedicated to crafting and distributing solutions that enhance the quality and longevity of products w...orldwide. With a focus on innovation and sustainability, the company develops high-performance ingredients and additive blends for diverse applications. From extending the shelf life of consumables to enriching the sensory appeal of everyday items, Camlin Fine Sciences consistently pushes the boundaries of chemical science. With a commitment to research and development, the company aims to create novel and environmentally responsible solutions that meet the ever-evolving needs of its global customer base. The company’s portfolio is built upon a foundation of robust research and development, leading to a range of advanced chemical solutions. They deliver shelf-life enhancement solutions such as TBHQ, BHA, BHT, and ASP. Camlin Fine Sciences serves various industries, offering customized solutions that address specific challenges and requirements. Furthermore, they are leaders in aroma ingredients, including vanillin and ethyl vanillin, and their commitment to quality and consistency has earned them a reputation as a trusted partner for manufacturers seeking to elevate their products and extend shelf life. Driven by a global perspective, Camlin Fine Sciences operates with a dedication to excellence and ethical business practices. The company understands the importance of regulatory compliance and strives to meet the highest standards of safety and environmental stewardship. With a network that spans across continents, Camlin Fine Sciences is committed to serving customers wherever they operate, providing reliable access to its innovative chemical solutions. With a long-term vision and a focus on sustainable growth, Camlin Fine Sciences is well-positioned to remain a leading player in the specialty chemicals industry.

Company Details

Symbol:CAMLINFINE
Industry:Specialty Chemicals
Sector:Specialty Chemicals

Key Leadership

Mr. Ashish Subhash Dandekar
Chairman & MD
Mr. Nirmal Vinod Momaya
MD & Director
Mr. Arjun Sudhakar Dukane
Executive Director of Technical & Executive Director

CAMLINFINE Share Price: Frequently Asked Questions

What is the current share price of Camlin Fine Sciences Limited?

Camlin Fine Sciences Limited (CAMLINFINE) trades at ₹99.63 on NSE and BSE. Market cap ₹1.91K (Cr). Educational data only.

What is the P/E ratio of Camlin Fine Sciences Limited?

Camlin Fine Sciences Limited has a P/E of 369.00x vs industry average 31.95x.

What is the Bull Run score for Camlin Fine Sciences Limited?

Camlin Fine Sciences Limited has a Bull Run score of 0/100 based on 25+ financial parameters.

Does Camlin Fine Sciences Limited pay dividends?

Camlin Fine Sciences Limited has a dividend yield of 0.00%. Past dividends don't guarantee future payments.

What is the ROE of Camlin Fine Sciences Limited?

Camlin Fine Sciences Limited has ROE of 2.84%. Higher ROE indicates better use of shareholder equity.

What is the debt-to-equity ratio of Camlin Fine Sciences Limited?

Camlin Fine Sciences Limited has debt-to-equity of 0.64.

Is Camlin Fine Sciences Limited a good investment?

Bull Run gives Camlin Fine Sciences Limited a score of 0/100. This is not investment advice — consult a SEBI-registered advisor.